<DOC>
	<DOCNO>NCT02106416</DOCNO>
	<brief_summary>The purpose study develop novel technique integrate PET/MRI tracer kinetic analysis urologic malignancy .</brief_summary>
	<brief_title>Use PET/MRI Tracer Further Understanding Prostate Cancer Development</brief_title>
	<detailed_description>Patients schedule undergo gadolinium-enhanced MRI urologic malignancy recruit undergo PET/MRI employ simultaneous dynamic acquisition PET gadolinium-chelate data set . For initial technical development within pilot study , analysis perform attempt compute tracer delivery use input integrate MRI-perfusion analysis . Flow permeability obtain MR perfusion analysis , use compute inflow rate constant K1 . K1 , reflect transfer contrast , use compute metabolic uptake FDG organ well visible tumor . A determination make whether metabolic uptake successfully compute case . If , acquisition post-processing modification make subsequent case .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<criteria>The study population consist patient know urologic cancer schedule undergo MRI gadolinium routine care . Patients refer Urology Medical Oncology Departments participation study . Subjects select basis willingness ability participate likelihood complete study . Patients agree participate present fly inform subject available research study study contact information . participation entirely voluntary , subject may withdraw study time . Normal volunteer recruit access exist database normal volunteer maintain Radiology Research department . Normal MRI exclusion criterion apply , include follow list . A standard MRI safety form use identify potential condition warrant exclusion . Electrical implant cardiac pacemaker perfusion pump Ferromagnetic implant aneurysm clip , surgical clip , prosthesis , artificial heart , valve steel part , metal fragment , shrapnel , bullet , tattoo near eye , steel implant Ferromagnetic object jewelry metal clip clothe Claustrophobia History seizure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>prostate cancer</keyword>
	<keyword>bladder cancer</keyword>
	<keyword>MRI</keyword>
	<keyword>PET</keyword>
	<keyword>perfusion</keyword>
</DOC>